Research
Hormonal
Insulin resistance is a stronger predictor of sleep disordered breathing in women with Polycystic Ovary Syndrome (PCOS) than obesity, age, or testosterone levels.
If you have PCOS, get screened for sleep apnoea even if you are not obese. Your risk is driven largely by insulin resistance, not just your weight. Managing blood sugar and insulin sensitivity is crucial for your sleep health.
GoodSupportsHIGH confidence
The backward conditional analysis eliminated all variables but insulin and glucose to insulin ratio, suggesting that insulin resistance was a stronger predictor for sleep apnoea than age, BMI, or testosterone.
Why this rating
Logistical regression analysis on a specific clinical population (PCOS women).
Source
Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance
Alexandros N. Vgontzas et al. · Journal of Internal Medicine · 2003
DOI 10.1046/j.1365-2796.2003.01177.x
narrative_reviewCited 321×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Obstructive sleep apnoea (OSA) contributes to the development of insulin resistance and elevated inflammatory cytokines (IL-6, TNF-alpha) independently of obesity, with visceral fat being the primary anatomical driver.Good
- Visceral fat, rather than total body fat or subcutaneous fat, is the primary anatomical parameter linked to the severity of sleep apnoea.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →